IRIDEX Corp [IRIX] stock prices are down -0.97% to $1.02 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The IRIX shares have gain 7.55% over the last week, with a monthly amount glided 27.50%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
On January 26, 2016, Singular Research initiated with a Buy rating and assigned a price target of $11.50 on the stock. First Albany started tracking the stock assigning a Buy rating and suggested a price target of $15.50 on January 03, 2007.
The stock price of IRIDEX Corp [IRIX] has been fluctuating between $0.78 and $3.29 over the past year. IRIDEX Corp [NASDAQ: IRIX] shares were valued at $1.02 at the most recent close of the market.
Analyzing the IRIX fundamentals
The IRIDEX Corp [NASDAQ:IRIX] reported sales of 48.67M for trailing twelve months, representing a surge of 1.91%. Gross Profit Margin for this corporation currently stands at 0.4% with Operating Profit Margin at -0.17%, Pretax Profit Margin comes in at -0.18%, and Net Profit Margin reading is -0.18%. To continue investigating profitability, this company’s Return on Assets is posted at -0.31, Equity is -2.31 and Total Capital is -0.66. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of2.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.9867 points at the first support level, and at 0.9533 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.0467, and for the 2nd resistance point, it is at 1.0733.
Ratios To Look Out For
It’s worth pointing out that IRIDEX Corp [NASDAQ:IRIX]’s Current Ratio is 1.42. In addition, the Quick Ratio stands at 0.77 and the Cash Ratio stands at 0.14. Considering the valuation of this stock, the price to sales ratio is 0.35, the price to book ratio is 8.09.
Transactions by insiders
Recent insider trading involved Grove Robert Earle, Director, that happened on Apr 17 ’25 when 8000.0 shares were purchased.